F13.24
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic use disorder, moderate, with sedative, hypnotic, or anxiolytic-induced bipolar or related disorder
- Sedative, hypnotic, or anxiolytic use disorder, moderate, with sedative, hypnotic, or anxiolytic-induced depressive disorder
- Sedative, hypnotic, or anxiolytic use disorder, severe, with sedative, hypnotic, or anxiolytic-induced bipolar or related disorder
- Sedative, hypnotic, or anxiolytic use disorder, severe, with sedative, hypnotic, or anxiolytic-induced depressive disorder
Medical Intelligence & Overview
ICD-10 code F13.24 refers to a condition characterized by dependence on sedatives, hypnotics, or anxiolytics that is accompanied by mood disturbances induced by these substances. This condition can significantly impact mental health and daily functioning, leading to complex treatment challenges. It involves not only the physical and psychological reliance on such medications but also the development of mood disorders like depression or bipolar-type episodes influenced by substance use.
Causes & Symptoms
Clinical Causes: Chronic use of sedatives, hypnotics, or anxiolytics beyond prescribed durations Misuse or recreational use of these medications Self-medication for underlying mental health issues such as anxiety or sleep disturbances Genetic predisposition to substance dependence Psychosocial factors including stress, trauma, or social influences Inadequate monitoring or supervision when using these medications
Key Symptoms: Craving or a strong desire to use sedatives, hypnotics, or anxiolytics Tolerance, requiring higher doses for the same calming or sleep-inducing effect Withdrawal symptoms like agitation, sweating, nausea, or tremors if use is reduced or stopped Persistent desire or unsuccessful efforts to cut down or control use Preoccupation with obtaining or using these substances Neglect of responsibilities at work, home, or social settings Mood disturbances such as depressed mood, irritability, or mood swings Episodes of elevated mood, euphoria, or irritability associated with mood disorder induced by substance use Sleep problems, either insomnia or excessive sleepiness Feelings of guilt or shame related to substance use and mood changes
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a comprehensive assessment including patient history, physical examination, and psychological evaluation. Healthcare providers look for patterns of substance use, signs of dependence, and mood symptoms linked to medication intake. Diagnostic criteria typically follow standards set by the DSM (Diagnostic and Statistical Manual of Mental Disorders) and are supported by laboratory tests or medical history to rule out other causes. Monitoring patterns of use and mood fluctuations over time help establish the link between substance dependence and mood disorders.
Treatment Protocols: Effective management encompasses multiple approaches tailored to individual needs, aiming to reduce dependence and stabilize mood symptoms. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is F13.24 a billable ICD-10 code?
Yes, F13.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.24?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference